NovaBridge Biosciences
-
Ticker
IMAB
NBP
-
Industry
Biotechnology More
-
Sector
Healthcare More
- 11-50 Employees
- Based in Rockville, Maryland
NovaBridge Biosciences (Nasdaq: NBP) is a global biotechnology company advancing a portfolio of therapeutic programs in oncology and ophthalmology. The Company identifies differentiated therapeutic opportunities, generates value-defining clinical evidence, and applies the development, financing, and partnering strategy best suited to each program. NovaBridge’s portfolio is led by givastomig
…More and VIS-101. The Company's objective is to build a sustainable biotechnology company by repeatedly identifying differentiated innovation, advancing it efficiently, and bringing novel therapies to patients through the path best suited to each opportunity.
NovaBridge Biosciences
Most Recent Responsibility Report
MOST RECENT
2021 Environmental, Social & Governance Report
Report Locked. NovaBridge Biosciences has reached its limit for free report views.
Our service enables potential investors to review the most recent and archived NovaBridge Biosciences Sustainability Report, NovaBridge Biosciences Corporate Social Responsibility Report, NovaBridge Biosciences CSR Report, NovaBridge Biosciences Corporate Responsibility, NovaBridge Biosciences CR Report, NovaBridge Biosciences Citizenship Report, NovaBridge Biosciences ESG Report, and NovaBridge Biosciences Environmental Report online.